BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 10, 2011
 |  BioCentury  |  Product Development

$150 million brass ring

BVGH offering $150M in prizes to create fever diagnostic for developing world

While grants have been the main tool foundations use to support drugs and diagnostics for the developing world, they can be an inefficient use of capital. BIO Ventures for Global Health believes its milestone-based prize for a point-of-care diagnostic to determine the cause of a fever could give foundations a bigger bang for the buck.

In June, BVGH announced plans for its Global Health Innovation Quotient (IQ) Prize to develop a multiplex POC diagnostic that would be able to distinguish between malaria and bacterial and viral causes of fever, and could be easily used in the developing world.

BVGH has yet to officially launch the IQ Prize. The organization is in the process of raising money from potential investors like foundations and the National Institutes of Health (NIH).

According to CEO Melinda Moree, children presenting with high temperatures are often misdiagnosed with malaria when they have a bacterial or viral infection or misdiagnosed with a bacterial infection when they have something else. Treatment based on this misdiagnosis results in increased antimalarial and antibiotic resistance - not to mention deaths when treatment for the correct infection is delayed.

The not-for-profit estimates a diagnostic could reduce the overall mortality...

Read the full 974 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >